Introduction: Campylobacter jejuni (C. jejuni) is one of the commonest causes of infective diarrhoea worldwide effecting mainly young children (<5 years) both in developing countries and the western world (1). The clinical spectrum varies from mild watery to bloody, inflammatory diarrhoea and is frequently associated with post infectious extraintestinal complications such as Guillain-Barré Syndrome (2). Despite the serious health problem caused by the bacterium, disease pathogenesis remains poorly understood. Bacterial adhesion and invasion of the intestinal epithelium is known to be a critical feature of infection (3). Human beta defensins (hBDs), a family of epithelial antimicrobial peptides are a major component of innate host defence (4). We and others have highlighted the role of these peptides during gastrointestinal infection and inflammation (5). In the present study we have investigated the role of hBDs during C.jejuni infection. Methods: Human colonic intestinal cell line (Caco-2) was infected with virulent strain (NCTC 11168) of C. jejuni. Both time and dose dependent studies of hBD gene expression were assessed by RT-PCR. The bactericidal activity of recombinant hBD-1,-2,-3 against wild type and isogenic mutants of C. jejuni was evaluated by broth-dilution assay. Results: A marked time-dependent induction of hBD3 was observed with maximal expression at 8 hours post-infection. In contrast hBD2 gene expression was modest. Importantly the bacterium was found to be highly susceptible to the antimicrobial action of hBD-3 amongst the peptides tested. Conclusion: The present study provides evidence for dynamic cross talk between the bacterium and host epithelial innate defence. The potent bactericidal activity of hBD3 may contribute to the self-limiting nature of the infection via enhanced bacterial clearance in a healthy host.